Tumor markers with high sensitivity and specificity have not yet been validated for ccRCC screening, but some candidate molecules have been recently proposed, such as aquaporin 1 (AQP1) and perilipin 2 (PLIN2). This evidence concerns the gene PLIN2 and nonpapillary renal cell carcinoma.